Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise

INTRODUCTION. Current scientific knowledge in the field of molecular biology and the associated manufacturing and technical capabilities enable the development of radiopharmaceuticals (RPs) with high specificity to the target organs, tissues, and receptors. The development of novel RPs requires mand...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Goryachev, I. V. Lysikova, A. A. Chernaia, D. D. Kushnir
Format:	Article
Language:	Russian
Published:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2025-02-01
Series:	Регуляторные исследования и экспертиза лекарственных средств
Subjects:	clinical trials protocol radiopharmaceuticals efficacy safety dosimetry therapeutic radiopharmaceuticals diagnostic radiopharmaceuticals guidelines registration dossier theranostic pairs
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/721
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines
by: Shijin Xuan, et al.
Published: (2020-01-01)

Strategies for Innovative Development of Tumor-targeted Theranostic Radiopharmaceuticals
by: HUANG Xuhu1, 2, 3, CHEN Huan1, 2, 3, LI Kexin1, 2, 3, WANG Ning1, 2, 3, ZHUANG Jin1, 2, 3, LI Hongyu1, 2, 3, DU Jin2, 3, 4
Published: (2025-04-01)

Toward the standardization of radiopharmaceutical therapies: a technical note evaluating a clinical dosimetry workflow for single-time-point 177Lu SPECT/CT-based therapies
by: Taehyung Peter Kim, et al.
Published: (2025-08-01)

Initial experience with use of infrared assistance for intravenous injection of radiopharmaceuticals
by: Ashok Kumar, et al.
Published: (2021-04-01)

Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)

Nanoradiopharmaceuticals: Design Principles, Radiolabeling Strategies, and Biomedicine Applications
by: Andrés Núñez-Salinas, et al.
Published: (2025-07-01)

Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute
by: Kanhaiyalal Agrawal, et al.
Published: (2025-04-01)

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
by: G. E. Kodina, et al.
Published: (2022-10-01)

The main issues of quality assurance of radiopharmaceuticals
by: G. E. Kodina, et al.
Published: (2019-12-01)

Comparison of tumour segmentation methods for dosimetry in [177Lu]Lu-PSMA I&T treated patients with metastatic castration resistant prostate cancer
by: Peter Frøhlich Staanum, et al.
Published: (2025-07-01)

ANALYSIS OF TECHNICAL AND HUMAN RESOURCES PROVISIONS FOR OPERATION OF RADIOISOTOPE DIAGNOSTIC DEPARTMENTS IN SAINT-PETERSBURG
by: N. M. Vishnyakova, et al.
Published: (2017-01-01)

Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysis
by: Mingye Zhao, et al.
Published: (2025-07-01)

Peptide‐Based Biomaterials as a Promising Tool for Cancer Radiotherapy
by: Qian Wang, et al.
Published: (2025-08-01)

To be GMP or not to be– a radionuclide’s question
by: Clemens Decristoforo, et al.
Published: (2025-07-01)

Immunomodulatory effects of alpha vs beta radiopharmaceutical therapy in murine prostate cancer
by: Carolina A. Ferreira, et al.
Published: (2025-05-01)

Amplification of Higher-Order Salivary Gland Volume Effects from External Beam Radiotherapy in Normal Tissue Complication Probability Modeling of Radiopharmaceutical Therapy
by: Chunming Gu, et al.
Published: (2025-02-01)

Ways to reduce radioactivity accumulation in the kidney during targeted therapy using small molecules, peptides and antibody fragments
by: K. O. Avrov, et al.
Published: (2024-09-01)

Justification of differential approach to management of patient biological waste in nuclear medicine departments
by: L. A. Chipiga, et al.
Published: (2023-01-01)

177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
by: Mathilde Ponchelle, et al.
Published: (2025-05-01)

Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery
by: Muath Almaslamani, et al.
Published: (2025-08-01)

EXTRAOSSEOUS ABNORMALITIES AND ARTIFACTS IN SKELETAL SCINTIGRAPHY
by: S. P. Mironov, et al.
Published: (2016-05-01)

Radiation protection considerations with [89Zr]Zr-girentuximab PET and surgery
by: Adnan Chowdhury, et al.
Published: (2025-05-01)

Developing ether and alcohol based extraction chromatography resins for purification of antimony-119 in nuclear medicine
by: Aivija Grundmane, et al.
Published: (2025-08-01)

Features and Practical Aspects of Radiochemical Purity Determination of Receptor-Specific Lu-177 Radiopharmaceuticals as Exemplified by [<sup>177</sup>Lu]Lu–PSMA-617
by: A. A. Larenkov, et al.
Published: (2022-12-01)

Management of biological waste of patients after radionuclide therapy
by: L. A. Chipiga, et al.
Published: (2022-06-01)

Precautions for certain categories of individuals in contact with a patient after radionuclide therapy
by: L. A. Chipiga, et al.
Published: (2025-04-01)

A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression
by: Esther Olaniran Håkansson, et al.
Published: (2025-08-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

Pharmaceutical development and practical approach to synthesis of tropantiol radiopharmaceutical ([<sup>99m</sup>Tc]Tc-TRODAT-1) for diagnostic of neurodegenerative diseases (review)
by: E. P. Pavlenko, et al.
Published: (2025-03-01)

Optimization of a GMP-compliant automated one-pot synthesis of Al[18F]F-NOTA-Ubiquicidin29 − 41 for bacterial infection imaging by PET/CT
by: Anna Meyer, et al.
Published: (2025-07-01)

αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin
by: Jana Rehm, et al.
Published: (2024-11-01)

Toxicity study of TEoS-DAZA, a chemical precursor for functional liver imaging with PET/CT
by: Julia Greiser, et al.
Published: (2025-05-01)

Scintigraphy with <sup>199</sup>Tl-chloride in diagnostics of nonspecific inflammatory diseases of small pelvis organs among women
by: A. P. Kurajov, et al.
Published: (2005-09-01)

The tumour sink effect on 68Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study
by: Atefeh Zamanian, et al.
Published: (2025-07-01)

Patient organ and effective dose estimation in radionuclide therapy with <sup>223</sup>Ra -dichloride
by: L. A. Chipiga, et al.
Published: (2020-12-01)

Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors
by: N. Yu. Velts, et al.
Published: (2024-10-01)

SPECIFIC ASPECTS OF BENEFIT-RISK EVALUATION OF HERBAL MEDICINAL PRODUCTS: ANALYSIS OF REGISTRATION DOSSIERS
by: N. G. Olenina, et al.
Published: (2018-06-01)

Planning a clinical trial programme for medicinal products for chronic constipation: An analysis of the European Medicines Agency Guideline
by: I. A. Proskurina, et al.
Published: (2025-05-01)

Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad
by: V. A. Shevtsov, et al.
Published: (2019-03-01)

Presentación: Producción, distribución, exhibición y consumo cinematográfico en la Argentina
by: Carolina Barnes, et al.
Published: (2014-07-01)